3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Recruiting
1
No longer available
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myeloid, Acute
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Myelodysplastic Syndromes
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
fludarabine
2
Busulfan
2
pembrolizumab
1
merphos
1
itacitinib
1
Thiotepa
1
Tacrolimus
1
Pam2CSK4 acetate and ODN M362 combination
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Imatinib Mesylate
1
INCB039110
1
Granulocyte Colony-Stimulating Factor
1
Cytarabine
1
Cyclophosphamide
1
Cladribine
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Hematologic Diseases
×
Bone Marrow Transplantation
×
Clear all
NCT04282174
2022-09-27
2019-KOE-001
Baptist Health South Florida
Phase 2
Withdrawn